Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli Proteins | 12 | 2023 | 126 | 2.300 |
Why?
|
| Enterotoxins | 14 | 2023 | 33 | 1.960 |
Why?
|
| Bacterial Toxins | 12 | 2015 | 44 | 1.650 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2023 | 5 | 0.890 |
Why?
|
| Adjuvants, Immunologic | 6 | 2015 | 107 | 0.880 |
Why?
|
| Ovalbumin | 5 | 2015 | 47 | 0.830 |
Why?
|
| Cholera Toxin | 7 | 2023 | 39 | 0.830 |
Why?
|
| Receptors, Cell Surface | 6 | 2015 | 144 | 0.750 |
Why?
|
| G(M1) Ganglioside | 7 | 2002 | 14 | 0.740 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2015 | 29 | 0.720 |
Why?
|
| B-Lymphocytes | 4 | 2006 | 185 | 0.670 |
Why?
|
| Antigen Presentation | 3 | 2005 | 54 | 0.650 |
Why?
|
| Immunologic Factors | 1 | 2018 | 45 | 0.640 |
Why?
|
| T-Lymphocytes | 5 | 2015 | 357 | 0.630 |
Why?
|
| Copper | 1 | 2018 | 105 | 0.610 |
Why?
|
| Chickens | 1 | 2018 | 133 | 0.610 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 149 | 0.570 |
Why?
|
| Lymphocyte Activation | 7 | 2006 | 236 | 0.560 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 183 | 0.530 |
Why?
|
| Mice | 15 | 2023 | 5913 | 0.380 |
Why?
|
| Antigens | 2 | 2005 | 56 | 0.360 |
Why?
|
| Animals | 21 | 2023 | 15081 | 0.350 |
Why?
|
| Escherichia coli | 6 | 2002 | 453 | 0.310 |
Why?
|
| Anthocyanins | 1 | 2016 | 5 | 0.280 |
Why?
|
| Sorghum | 1 | 2016 | 3 | 0.280 |
Why?
|
| Toxoplasma | 1 | 2016 | 9 | 0.270 |
Why?
|
| Antiprotozoal Agents | 1 | 2016 | 30 | 0.270 |
Why?
|
| Muramidase | 1 | 2005 | 22 | 0.250 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2023 | 22 | 0.220 |
Why?
|
| Plant Extracts | 1 | 2016 | 286 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 6 | 2010 | 661 | 0.210 |
Why?
|
| Hot Temperature | 1 | 2023 | 128 | 0.210 |
Why?
|
| Mammals | 1 | 2023 | 105 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2001 | 259 | 0.200 |
Why?
|
| Lymphokines | 1 | 2001 | 13 | 0.200 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2006 | 18 | 0.190 |
Why?
|
| Immunoglobulin G | 3 | 1995 | 237 | 0.190 |
Why?
|
| Signal Transduction | 4 | 2006 | 1908 | 0.190 |
Why?
|
| Antigens, Bacterial | 2 | 1991 | 132 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 1998 | 159 | 0.170 |
Why?
|
| Immune Tolerance | 1 | 1999 | 65 | 0.160 |
Why?
|
| Guanylate Cyclase | 2 | 1998 | 18 | 0.160 |
Why?
|
| Receptors, Peptide | 2 | 1998 | 23 | 0.160 |
Why?
|
| Antibodies, Bacterial | 2 | 1996 | 109 | 0.160 |
Why?
|
| Cell Survival | 2 | 2015 | 864 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2018 | 208 | 0.140 |
Why?
|
| Cross-Linking Reagents | 1 | 1996 | 51 | 0.140 |
Why?
|
| Membrane Lipids | 1 | 1996 | 33 | 0.140 |
Why?
|
| Immunoglobulin A | 3 | 1995 | 58 | 0.140 |
Why?
|
| Lymphocyte Subsets | 1 | 1996 | 21 | 0.140 |
Why?
|
| H-2 Antigens | 1 | 1995 | 4 | 0.130 |
Why?
|
| Vaccines, Synthetic | 2 | 2010 | 72 | 0.130 |
Why?
|
| Interleukin-2 | 1 | 2015 | 89 | 0.120 |
Why?
|
| Streptococcus | 2 | 1991 | 16 | 0.120 |
Why?
|
| Alleles | 1 | 1995 | 321 | 0.120 |
Why?
|
| Mammary Glands, Animal | 2 | 1991 | 26 | 0.120 |
Why?
|
| Autoimmune Diseases | 3 | 1999 | 57 | 0.120 |
Why?
|
| Dose-Response Relationship, Immunologic | 2 | 2005 | 24 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2015 | 326 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 617 | 0.110 |
Why?
|
| Vaccines | 2 | 1998 | 55 | 0.110 |
Why?
|
| Epitopes | 1 | 1993 | 148 | 0.110 |
Why?
|
| Apoptosis | 2 | 1998 | 1398 | 0.100 |
Why?
|
| Drug Carriers | 1 | 1993 | 125 | 0.100 |
Why?
|
| Macrophages | 1 | 2015 | 439 | 0.100 |
Why?
|
| Cell Line | 1 | 2015 | 1354 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 1999 | 1568 | 0.090 |
Why?
|
| Enterovirus B, Human | 1 | 2010 | 2 | 0.090 |
Why?
|
| HIV Core Protein p24 | 1 | 2010 | 10 | 0.090 |
Why?
|
| AIDS Vaccines | 1 | 2010 | 30 | 0.090 |
Why?
|
| Mice, Inbred CBA | 2 | 2006 | 38 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2016 | 1518 | 0.090 |
Why?
|
| src-Family Kinases | 2 | 2006 | 46 | 0.080 |
Why?
|
| Female | 7 | 2018 | 20969 | 0.080 |
Why?
|
| Ligands | 2 | 2006 | 349 | 0.070 |
Why?
|
| Chemical Fractionation | 1 | 2016 | 11 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 1999 | 409 | 0.070 |
Why?
|
| Apigenin | 1 | 2016 | 13 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2006 | 21 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 83 | 0.070 |
Why?
|
| Biological Assay | 1 | 2016 | 59 | 0.070 |
Why?
|
| Plant Leaves | 1 | 2016 | 124 | 0.070 |
Why?
|
| Haplotypes | 1 | 2006 | 182 | 0.060 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2005 | 5 | 0.060 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 20 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 201 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 132 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 21 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 101 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 132 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 187 | 0.060 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2005 | 55 | 0.060 |
Why?
|
| Antibodies | 1 | 2005 | 141 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 133 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 290 | 0.060 |
Why?
|
| Cell Communication | 1 | 2005 | 97 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2016 | 272 | 0.060 |
Why?
|
| DNA Replication | 1 | 2005 | 152 | 0.060 |
Why?
|
| Kinetics | 1 | 2005 | 708 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1039 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2005 | 308 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2016 | 308 | 0.050 |
Why?
|
| Pinocytosis | 1 | 2002 | 8 | 0.050 |
Why?
|
| Models, Molecular | 2 | 1999 | 808 | 0.050 |
Why?
|
| Carbohydrate Sequence | 2 | 1999 | 22 | 0.050 |
Why?
|
| Integrin alphaXbeta2 | 1 | 2001 | 2 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 2001 | 20 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2010 | 224 | 0.050 |
Why?
|
| Receptors, Guanylate Cyclase-Coupled | 2 | 1998 | 2 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 502 | 0.050 |
Why?
|
| Collagen | 2 | 1999 | 172 | 0.050 |
Why?
|
| Interferon-gamma | 2 | 1999 | 250 | 0.050 |
Why?
|
| Pregnancy | 3 | 1991 | 1549 | 0.050 |
Why?
|
| Protein Binding | 3 | 1999 | 972 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2001 | 113 | 0.050 |
Why?
|
| Male | 2 | 2018 | 20025 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 1609 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2002 | 381 | 0.040 |
Why?
|
| Immunization | 2 | 2010 | 92 | 0.040 |
Why?
|
| Cattle | 2 | 1991 | 477 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1991 | 448 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 1999 | 45 | 0.040 |
Why?
|
| Arthritis | 1 | 1999 | 15 | 0.040 |
Why?
|
| Glycosphingolipids | 1 | 1998 | 5 | 0.040 |
Why?
|
| Th2 Cells | 1 | 1999 | 58 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 1999 | 132 | 0.040 |
Why?
|
| Autoantigens | 1 | 1999 | 81 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 1999 | 54 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1999 | 68 | 0.040 |
Why?
|
| Protein Conformation | 1 | 1999 | 389 | 0.040 |
Why?
|
| Lymphocytes | 1 | 1998 | 118 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1997 | 32 | 0.040 |
Why?
|
| Arthritis, Experimental | 1 | 1997 | 5 | 0.040 |
Why?
|
| Time Factors | 1 | 2002 | 1742 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1997 | 56 | 0.040 |
Why?
|
| Antibody Formation | 2 | 1997 | 74 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 1997 | 142 | 0.040 |
Why?
|
| Cell Division | 1 | 1997 | 307 | 0.040 |
Why?
|
| HIV Infections | 1 | 2010 | 2303 | 0.030 |
Why?
|
| Immunologic Capping | 1 | 1996 | 2 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 1996 | 57 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 188 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 286 | 0.030 |
Why?
|
| Feces | 1 | 1995 | 111 | 0.030 |
Why?
|
| Up-Regulation | 1 | 1997 | 513 | 0.030 |
Why?
|
| Base Sequence | 1 | 1996 | 997 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 515 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1994 | 1180 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 1015 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 1371 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1993 | 116 | 0.030 |
Why?
|
| Humans | 4 | 2016 | 37093 | 0.030 |
Why?
|
| Vibrio cholerae | 1 | 1993 | 98 | 0.030 |
Why?
|
| Cytokines | 1 | 1996 | 602 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1993 | 295 | 0.030 |
Why?
|
| Infusions, Parenteral | 1 | 1991 | 12 | 0.020 |
Why?
|
| Rats | 1 | 1999 | 3483 | 0.020 |
Why?
|
| Milk Proteins | 1 | 1991 | 29 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1991 | 82 | 0.020 |
Why?
|
| Permeability | 1 | 1990 | 67 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 108 | 0.020 |
Why?
|
| Epithelium | 1 | 1990 | 79 | 0.020 |
Why?
|
| Vaccines, Attenuated | 1 | 2010 | 72 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1990 | 67 | 0.020 |
Why?
|
| Phagocytosis | 1 | 1990 | 69 | 0.020 |
Why?
|
| Neutrophils | 1 | 1990 | 131 | 0.020 |
Why?
|
| Lactation | 1 | 1988 | 40 | 0.020 |
Why?
|
| Milk | 1 | 1988 | 50 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2010 | 262 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2006 | 47 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 2231 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 1997 | 71 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1997 | 72 | 0.010 |
Why?
|
| Immunotherapy | 1 | 1998 | 95 | 0.010 |
Why?
|
| Membrane Fusion | 1 | 1994 | 11 | 0.010 |
Why?
|
| Eukaryotic Cells | 1 | 1994 | 36 | 0.010 |
Why?
|